XML 21 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue
 3 Months Ended
Mar. 31, 2020
Revenue  
Revenue

7.           Revenue

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

(in thousands)

    

2019

    

2020

    

Product revenue, net

 

$

 —

 

$

156

 

Collaboration revenues

 

 

1,000

 

 

145

 

Research premium

 

 

393

 

 

290

 

Government grants

 

 

311

 

 

198

 

Total

 

$

1,703

 

$

789

 

 

The $1.0 million of collaboration revenue for the three months ended March 31, 2019 reflects the upfront payment under the Sunovion License Agreement  received in April 2019 (see Note 11). Product revenue, net, relate to sales of XENLETA.